iGMDRD74
Canonical SMILES: CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O
InChI: InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1
InChI Key: XDXDZDZNSLXDNA-TZNDIEGXSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Standard NameIdarubicin CHEMBLCHEMBL1117 CHEMBL1200976 Pubchem CID42890 KEGG Drug IDD08062 DRUGBANK IDDB01177 Drug StatusAlone Drug targets (TTD)DAP000050 Drug TypeSmall Molecule |
Drug Class:
Anthracycline Topoisomerase InhibitorAnthracyclinesAnthracyclines and Related SubstancesAntibiotics, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsCarbohydratesCardiotoxic antineoplastic agentsCytochrome P-450 Enzyme InhibitorsCytotoxic Antibiotics and Related SubstancesDaunorubicinEnzyme InhibitorsGlycosidesHydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicImmunosuppressive AgentsMyelosuppressive AgentsNaphthacenesPolycyclic CompoundsPolycyclic Hydrocarbons, AromaticTopoisomerase II InhibitorsTopoisomerase InhibitorsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Idarubicin
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |